Original article
Clinical impact of Ga68-DOTATOC PET/CT on neuroendocrine tumors. A preliminary experience
Impacto clínico del PET/TC Ga68-DOTATOC en tumores de origen neuroendocrino. Experiencia preliminar
Read
5984
Timeswas read the article
1497
Total PDF
4487
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 47 | 110 | 157 |
| 2025 11 | 210 | 311 | 521 |
| 2025 10 | 100 | 75 | 175 |
| 2025 9 | 90 | 47 | 137 |
| 2025 8 | 109 | 33 | 142 |
| 2025 7 | 126 | 34 | 160 |
| 2025 6 | 111 | 16 | 127 |
| 2025 5 | 122 | 11 | 133 |
| 2025 4 | 124 | 34 | 158 |
| 2025 3 | 103 | 21 | 124 |
| 2025 2 | 109 | 14 | 123 |
| 2025 1 | 146 | 19 | 165 |
| 2024 12 | 110 | 9 | 119 |
| 2024 11 | 85 | 21 | 106 |
| 2024 10 | 78 | 16 | 94 |
| 2024 9 | 90 | 18 | 108 |
| 2024 8 | 81 | 29 | 110 |
| 2024 7 | 113 | 15 | 128 |
| 2024 6 | 40 | 21 | 61 |
| 2024 5 | 63 | 18 | 81 |
| 2024 4 | 95 | 24 | 119 |
| 2024 3 | 110 | 11 | 121 |
| 2024 2 | 165 | 18 | 183 |
| 2024 1 | 171 | 9 | 180 |
| 2023 12 | 104 | 18 | 122 |
| 2023 11 | 110 | 13 | 123 |
| 2023 10 | 141 | 11 | 152 |
| 2023 9 | 96 | 12 | 108 |
| 2023 8 | 101 | 3 | 104 |
| 2023 7 | 106 | 5 | 111 |
| 2023 6 | 85 | 12 | 97 |
| 2023 5 | 116 | 7 | 123 |
| 2023 4 | 100 | 3 | 103 |
| 2023 3 | 87 | 3 | 90 |
| 2023 2 | 56 | 11 | 67 |
| 2023 1 | 70 | 11 | 81 |
| 2022 12 | 76 | 16 | 92 |
| 2022 11 | 67 | 19 | 86 |
| 2022 10 | 47 | 30 | 77 |
| 2022 9 | 59 | 30 | 89 |
| 2022 8 | 48 | 23 | 71 |
| 2022 7 | 45 | 9 | 54 |
| 2022 6 | 36 | 9 | 45 |
| 2022 5 | 32 | 23 | 55 |
| 2022 4 | 44 | 31 | 75 |
| 2022 3 | 43 | 33 | 76 |
| 2022 2 | 32 | 35 | 67 |
| 2022 1 | 48 | 37 | 85 |
| 2021 12 | 25 | 27 | 52 |
| 2021 11 | 38 | 39 | 77 |
| 2021 10 | 26 | 32 | 58 |
| 2021 9 | 14 | 18 | 32 |
| 2021 8 | 14 | 20 | 34 |
| 2021 7 | 9 | 14 | 23 |
| 2021 6 | 14 | 9 | 23 |
Show all
